AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.480
+0.050 (2.06%)
At close: Sep 15, 2025, 4:00 PM EDT
2.520
+0.040 (1.61%)
After-hours: Sep 15, 2025, 7:33 PM EDT
AC Immune Stock Forecast
Stock Price Forecast
The 2 analysts that cover AC Immune stock have a consensus rating of "Strong Buy" and an average price target of $10, which forecasts a 303.23% increase in the stock price over the next year. The lowest target is $8.00 and the highest is $12.
Price Target: $10 (+303.23%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AC Immune stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +222.58% | Sep 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $16 → $12 | Strong Buy | Maintains | $16 → $12 | +383.87% | May 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +545.16% | Apr 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +545.16% | Mar 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +545.16% | Nov 15, 2024 |
Financial Forecast
Revenue This Year
4.10M
from 27.31M
Decreased by -84.99%
Revenue Next Year
46.04M
from 4.10M
Increased by 1,022.98%
EPS This Year
-0.78
from -0.51
EPS Next Year
-0.42
from -0.78
Financial currency is CHF. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.3M | 94.5M | |||
| Avg | 4.1M | 46.0M | |||
| Low | 2.3M | 13.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -76.9% | 2,204.9% | |||
| Avg | -85.0% | 1,023.0% | |||
| Low | -91.7% | 227.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.74 | 0.02 | |||
| Avg | -0.78 | -0.42 | |||
| Low | -0.78 | -0.63 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.